Joseph E. Smith, Director at PAR PHARMACEUTICAL COMPANIES, INC. (PRX), bought 50,000 shares at $18.45 ($923K) on 2007-10-03, disclosed to the SEC on 2007-10-03.
Open-market purchase of $922k PRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| WBMD | SELL | 2014-02-26 | $268K | — | Filing → |
| WBMD | SELL | 2013-07-17 | $854K | — | Filing → |
| WBMD | SELL | 2011-05-16 | $448K | — | Filing → |